Investigational therapy BPN14770 has received orphan drug status from the U.S. Food and Drug Administration as a treatment for…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
The gene-editing technology CRISPR/Cas9 was able to restore the expression of the FMR1 gene in…
Loss of the fragile X mental retardation-1 (FMR1) gene is linked to an early decline in reproduction capacity due to…